FDA Warns About Triamcinolone and Moxifloxacin Combo for Eye

FDA Warns About Triamcinolone and Moxifloxacin Combo for EyeThe FDA issued a safety alert after serious adverse events were reported in at least 43 patients who received a compounded triamcinolone and moxifloxacin product by intravitreal injection.
News AlertsThe FDA issued a safety alert after serious adverse events were reported in at least 43 patients who received a compounded triamcinolone and moxifloxacin product by intravitreal injection.
News Alerts
Go to Source
Author:

Powered by WPeMatico